Your session is about to expire
← Back to Search
Value Champion Training for Dementia
N/A
Waitlist Available
Led By Lorella Palazzo, PhD
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will test whether training a clinician to be a 'value champion' can decrease the use of three classes of potentially inappropriate prescription medications among people living with dementia.
Eligible Conditions
- Dementia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Medication Possession Ratio for any medication in these three classes: antipsychotics, benzodiazepines, or hypoglycemic medication (sulfonylureas or insulin).
Secondary outcome measures
Number of Emergency Department or Hospitalizations attributed to a fall.
Number of equity related milestones achieved by each clinician champion during their project. Recorded in the Value Champions Project Workbook.
Number of milestones completed by the clinician champions during the "design and implement" phase of their improvement project- recorded in the Value Champions Project Workbook
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Value Champion Training ProgramExperimental Treatment1 Intervention
Intervention arm.
Group II: Standard CareActive Control1 Intervention
Control group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Value Champion Training Program
2023
N/A
~2150
Find a Location
Who is running the clinical trial?
Brown UniversityOTHER
456 Previous Clinical Trials
560,934 Total Patients Enrolled
19 Trials studying Dementia
206,172 Patients Enrolled for Dementia
Kaiser PermanenteLead Sponsor
538 Previous Clinical Trials
24,111,681 Total Patients Enrolled
10 Trials studying Dementia
195,704 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,669 Previous Clinical Trials
28,002,967 Total Patients Enrolled
265 Trials studying Dementia
23,621,264 Patients Enrolled for Dementia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Value Champion Training Program
- Group 2: Standard Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities to join this experiment at present?
"Unfortunately, this investigation is no longer searching for participants. All of the relevant information was initially published on June 15th 2023 and last updated on October 25th 2022; however, currently there are 764 other studies that require volunteers."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger